Assenagon Asset Management’s Voyager Therapeutics VYGR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,381	Closed	-$64.4K	–	1224
2025 Q4	$64.4K	Buy	+16,381	New	+$72.5K	﹤0.01%	1138
2024 Q2	–	Sell	-28,896	Closed	-$269K	–	1501
2024 Q1	$269K	Buy	28,896 +10,936	+61%	+$92.3K	﹤0.01%	1305
2023 Q4	$152K	Sell	17,960 -16,199	-47%	-$118K	﹤0.01%	1378
2023 Q3	$265K	Sell	34,159 -165,333	-83%	-$1.51M	﹤0.01%	1307
2023 Q2	$2.28M	Buy	199,492 +86,327	+76%	+$893K	0.01%	728
2023 Q1	$873K	Buy	+113,165	New	+$900K	﹤0.01%	1094
2022 Q4	–	Sell	-16,224	Closed	-$96K	–	1462
2022 Q3	$96K	Sell	16,224 -3,517	-18%	-$22.5K	﹤0.01%	1297
2022 Q2	$117K	Buy	+19,741	New	+$133K	﹤0.01%	1404
2021 Q4	–	Sell	-52,547	Closed	-$138K	–	1572
2021 Q3	$138K	Sell	52,547 -41,580	-44%	-$135K	﹤0.01%	1252
2021 Q2	$389K	Sell	94,127 -185,946	-66%	-$843K	﹤0.01%	1071
2021 Q1	$1.32M	Buy	280,073 +63,914	+30%	+$436K	0.01%	832
2020 Q4	$1.55M	Buy	216,159 +75,757	+54%	+$728K	0.01%	586
2020 Q3	$1.5M	Buy	+140,402	New	+$1.65M	0.01%	658